🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Context Therapeutics Inc.

CNTX Healthcare
$0.488 $-0.01 (-1.81%)
Market Cap: $44.79 M
Gurus Holding
1
Popularity Rank
#4655
% of Shares Held
1.13%
Net Activity (Q2 2026)
+$325,522.84

Guru Ownership Trend

Guru Analysis for Context Therapeutics Inc. (CNTX)

Context Therapeutics Inc. (CNTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $507,682.01.

Top institutional holders include Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $325,522.84 net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 469.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$475,467.84
Total Buy Value
New Buys 0
Additions 1
-$149,945
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
1

FAQs for Context Therapeutics Inc. (CNTX)

Major holders include Renaissance Technologies (RenTech) ($576,831). According to the latest reported data, 1 tracked investment managers collectively hold approximately 1.04 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $325,522.84, with 1 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited CNTX. The total reported sell value was $149,945.

Yes, 0 managers opened new positions in CNTX, and 1 increased their existing holdings. The total reported buy value was $475,467.84.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 469.1% 1,041,399 $576,831 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form